Navigation Links
Preliminary Lineup of Presenters Set for 7th Annual New York Stem Cell Summit
Date:8/25/2011

PHILADELPHIA, Aug. 25, 2011 /PRNewswire/ -- RRY Publications LLC today announced the preliminary lineup of presenters for the 7th Annual Stem Cell Summit. The Stem Cell Summit, an intensive one-day event, that allows attendees to learn about the latest developments in the stem cell marketplace, evaluate the groundbreaking stem cell products physicians are using today, and discover the growing market potential in terms of revenues. For 2012, the Summit will feature 30+ presenters, a research review & debate session, and a special track on expanding the range of stem cell therapies.

The 7th Annual Stem Cell Summit will take place on Feb. 21, 2012, at Bridgewaters in the heart of New York City's historic South Street Seaport. The preliminary roster of companies and products featured will include representatives from 2011 presenters and new 2012 presenters.3DM, Inc.

Histogen Inc.Aastrom Biosciences, Inc.

Incell Corporation, LLCAldagen, Inc.

MaxCyte, Inc.AllCells, LLC

Moraga Biotechnology CorporationAlloSource

NeoStem, Inc.Amedica Corp.

Neuronyx, Inc.Arteriocyte, Inc.

Novocell, Inc.Bio Life Solutions Inc.

NuVasive, Inc.BioE Corp.

Osiris Therapeutics, Inc.BioTime Inc.

Parcell Laboratories LLCCalifornia Stem Cell, Inc.

Pervasis Therapeutics, Inc.Cognate BioServices, Inc.

Progenitor Cell Therapy, Inc.Cord Blood America, Inc.

StemagenCore Dynamics Ltd.

Stemina, Inc.Cytori Therapeutics, Inc.

TiGenix NVGamida Cell Ltd.

Tissue Genesis, Inc.Geron Corp.

Vet-Stem, Inc.Harvest Technologies Corp.In addition to the company and product overviews, Robin Young, president of RRY Publications and the organizer of the annual Stem Cell Summit, will deliver his updated 10-year market forecast for the industry.

7th Annual New York Stem Cell Summit Facts at a GlanceWhat:Largest Gathering of Stem Cell Company Executives, Scientists, Investors, and PhysiciansWhen:February 21, 2012Where: Bridgewaters11 Fulton StreetNew York CityWho:The Stem Cell Summit is organized by RRY Publications LLCAdmission:$750 advance registration by September 30, 2011$1,500 Registration (February 1, 2012 – February 21, 2012 and onsite)Information:For more information on presentation or sponsorship opportunities, call Bharathi Kavalipati at 610-260-6462 or send an email to bharathi@ryortho.comAdditional information, including attendee registration details, is available at www.stemcellsummit.comContacts:

Suzanne KirchnerRRY Publications LLC501-570-0328skirchner@ryortho.com
'/>"/>

SOURCE RRY Publications LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
2. Generex Provides Preliminary Results of Generex Oral-lyn™ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance
3. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
4. Uroplasty on Preliminary List of Additions to Russell 3000® and Russell Global® Indexes
5. Delcath on Preliminary List of Additions to Russell Microcap® Index
6. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
7. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
8. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
11. Symmetry Medical Announces Preliminary Unaudited Full Year 2010 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/5/2017)... June 5, 2017 Kohll,s Pharmacy & Homecare is the ... the United States . The Raizer is a simple ... person up to an almost-standing position within a ... by one assistant and does not require any ... that a child can operate it, and lightweight ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... ... personal financial planning to families and business owners in North Central West Virginia, ... help provide services to differently abled residents in the region. , The Stepping ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease ... the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged ...
(Date:6/22/2017)... ... June 22, 2017 , ... Vighter, a premier provider ... certification for ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, South ... law has been degraded. The PSC.1 standard was created to protect fundamental freedoms ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, a premier ... private equity firm, has invested $3.35 million in the company. , “We ... Capital offers the smart money, speed to market and accountability we had been ...
Breaking Medicine News(10 mins):